The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,254.00
Ask: 12,256.00
Change: -72.00 (-0.58%)
Spread: 2.00 (0.016%)
Open: 12,324.00
High: 12,406.00
Low: 12,246.00
Prev. Close: 12,318.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Too soon to say if Britons can take summer holiday abroad, says UK's Johnson

Mon, 05th Apr 2021 07:49

* Summer holiday abroad? Too early to say, Johnson says

* UK to have traffic light system for travel

* International travel will not start before May 17

* England's economy to start to reopen from April 12

* Johnson to raise a pint on April 12
(Adds quotes and Heathrow disappointment)

By Kate Holton, Alistair Smout and Elizabeth Piper

LONDON, April 5 (Reuters) - British Prime Minister Boris
Johnson said on Monday it was too soon to say whether
international summer holidays can go ahead this year, a remark
suggesting a planned reopening of outbound travel could be
pushed back beyond May 17.

Britons are among Europe's highest spending tourists so the
fortunes of the continent's summer season and the travel
industry, hit hard by restrictions imposed on travel because of
the COVID-19 pandemic, will depend on when tourists can return
to the beaches, cafes and tavernas of southern Europe.

Asked about summer holidays, Johnson told reporters he did
not want the virus to be reimported into the United Kingdom from
other countries so it was not possible to give more clarity as
the global situation was evolving so fast.

"Obviously we are hopeful that we can get going from May
17th, but I do not wish to give hostages to fortune or to
underestimate the difficulties that we are seeing in some of the
destination countries that people might want to go to," he said.

"I wish I could give you more on that, I know that people
watching will want to know exactly what they can do from May 17,
but we're not there yet," Johnson said. "As soon as we have more
solid information, more solid data, we'll let you know."

A British government review of travel said that it was not
yet clear if tourists would have to wait beyond May 17 for the
outbound restrictions to be lifted.

The lack of clarity from Johnson disappointed Britain's
biggest airport and travel companies which said the sector was
teetering on the brink of collapse.

"It's disappointing that the opportunity has been missed to
provide more certainty to reunite families separated by travel
restrictions, to give sunseekers the confidence to book ahead
for their summer getaway," Heathrow CEO John Holland-Kaye said.

"A clearer timeline for the return to international travel
is needed," Holland-Kaye said.

Noel Josephides, chairman of travel group Sunvil, told
Reuters before Johnson spoke that the industry would need weeks
of notice to reopen hotels and resume flight routes.

"It is not possible to launch a tour operation with one or
two weeks' notice," he said.

Britain plans to use a traffic-light risk system for
countries once non-essential international travel resumes, but
the government said it was too early to say which countries
could be given the green light that would only require
coronavirus tests before and after travel.

VACCINE PASSPORTS

Countries that could fit on the green list include Portugal,
Malta, Israel, the United Arab Emirates and the United States.

Countries on the amber list would require self-isolation.
Those on the red list would require quarantine.

Airlines such as easyJet, Ryanair and
British Airways, plus holiday groups such as TUI
, hope to avoid a second lost summer but COVID-19
cases have risen in continental Europe.

Johnson said a planned reopening of the economy could take
place next week, with the opening of all shops, gyms,
hairdressers and outdoor hospitality areas in England.

With the vaccine rolling out rapidly across Britain and
infection numbers falling, Johnson said England could proceed to
Stage 2 of his roadmap out of lockdown from April 12.

"I will be going to the pub myself - and cautiously but
irreversibly raising a pint of beer to my lips," Johnson said.

Johnson also confirmed that the government was looking at a
COVID-19 status certification system, or vaccine passport, to
help reopen larger events and to travel.

"You've got to be very careful in how you handle this and
... don't start a system that's discriminatory."
(Editing by Guy Faulconbridge and Timothy Heritage; Editing by
Aurora Ellis)

More News
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.